Outcome of Endodontic Treatment and Retreatment With a Bioceramic Sealer
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorJuan Gonzalo Olivieri
About this trial
This study is a prospective randomized controlled study of patients who come to the University. The aim is to evaluate the success rate of treatment and retreatment of canals using BioRoot ™ RCS cement compared with AH Plus up to 6 years of follow-up. The null hypothesis is that there will be no statistically significant differences in rates of successful treatment of root canals filled with BioRoot ™ RCS compared to gutta-percha and AH Plus sealer.
Eligibility criteria
Qualifiers
Patients that demonstrate understanding of the study and willingness to participate as evidenced by signing the voluntary informed consent and received a signed and dated copy of the informed consent form.
Understands and is willing to comply with all study procedures and restrictions.
Not presence of clinically significant and relevant abnormalities of clinical history or oral examination.
Diagnosis of irreversible pulpitis or apical symptomatic / asymptomatic periodontitis.
Disqualifiers
General: Patients with systemic diseases, diabetes, immunocompromised and pregnant women, or any clinically significant or relevant oral abnormalities.
Specific: root resorption, root fractures, impossibility of restoration and cases were primary or secondary root canal treatment is not the treatment of choice.
Trial design
Treatments tested in this trial
- BioRoot RCS® root canal sealer
- AH Plus® root canal sealer
Treatment groups
220 Participants
are divided into 2 treatment groupsSponsors and collaborators
Juan Gonzalo Olivieri
Lead sponsor
Universitat Internacional de Catalunya
Sponsor institution
Source ClinicalTrials.gov